Microfluidic Droplet Cell Detection via PCR Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional molecular biology techniques face challenges in detecting rare cells due to limited sensitivity and specificity, often resulting in false positives and inability to provide single-cell resolution, especially in the presence of background cells and inhibitors.
Innovation Solution
The method involves encapsulating cells within microfluidic droplets, lysing them to release nucleic acids, selectively amplifying target nucleic acid sequences, and pooling the droplets to enhance the detection of rare cells through techniques like PCR.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional molecular biology techniques (e.g., real-time quantitative PCR) are used for detection, then the detection process is simple and fast, but the sensitivity is limited due to background cells, inhibitors, and noise
Solution Approach 1:
The patent applies segmentation by partitioning the cell population into individual single-cell suspensions, isolating each cell separately. This segmentation eliminates the interference from background cells and inhibitors that plague bulk detection methods, allowing sensitive detection of rare target cells by analyzing them in isolation rather than as part of a heterogeneous mixture
Solution Approach 2:
The patent extracts the target signal from the noisy background by isolating individual cells and their nucleic acids. By taking out single cells from the bulk population and performing amplification on individually isolated nucleic acids, the method extracts the微弱 target signal from the overwhelming background of non-target cells and inhibitors
2Measurement precision
If bulk methods are used for detection, then the analysis is straightforward, but single-cell resolution and detection capability are lost due to cell heterogeneity
Solution Approach 1:
The patent uses segmentation to divide the bulk cell population into discrete single-cell units. Each cell is individually isolated and processed, enabling single-cell resolution detection. This segmentation approach transforms an otherwise homogeneous bulk analysis into a series of discrete single-cell measurements, capturing cellular heterogeneity
Solution Approach 2:
The patent employs molecular copying through nucleic acid amplification (PCR) of single-cell DNA. By copying and amplifying the genetic material from each isolated single cell, the method generates sufficient signal for detection while maintaining single-cell resolution, effectively creating a detectable copy of the rare target cell's genetic signature
3Measurement precision
If single cells are isolated and analyzed individually, then single-cell resolution is achieved, but the detection sensitivity remains insufficient without amplification
Solution Approach 1:
The patent applies preliminary action by performing nucleic acid amplification (PCR) on the isolated single-cell DNA before detection. This preliminary amplification step increases the quantity of target nucleic acid from trace amounts in a single cell to detectable levels, enabling sensitive detection of rare cells while maintaining single-cell resolution
Solution Approach 2:
The patent changes the concentration parameter of nucleic acid through exponential amplification. By applying PCR cycles that exponentially increase the copy number of target DNA sequences, the method transforms the extremely low concentration of single-cell nucleic acid into a high concentration suitable for sensitive detection
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the ability to accurately determine rare cells by amplifying target nucleic acids, reducing noise and competition, and allowing for precise quantification and identification of rare cell types.
Implementation Method 1
within the interior of the droplets, applying conditions able to selectively amplify a target nucleic acid sequence suspected of being present within the nucleic acids released from the cells
Data Source
AI summary
The present invention generally relates to microfluidics and, in particular, to systems and methods for determining cells using amplification. In one set of embodiments, cells are encapsulated within droplets and nucleic acids from the cells amplified within the droplets. The droplets may then be pooled together and the amplified nucleic acids can be determined using PCR or other suitable techniques. In some embodiments, techniques such as these can be used to detect relatively rare cells that may be present, e.g., if the droplets are amplified using conditions able to selectively amplify nucleic acids arising from the relatively rare cells.